GSK J1
Synonym(s):3-((6-(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid; N-[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-Alanine;Histone Lysine Demethylase Inhibitor VII, GSK-J1 - CAS 1373422-53-7 - Calbiochem;JHDM Inhibitor II, 3-(6-(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-ylamino)propanoic acid
- CAS NO.:1373422-53-7
- Empirical Formula: C22H23N5O2
- Molecular Weight: 389.45
- MDL number: MFCD22683851
- EINECS: 200-258-5
- SAFETY DATA SHEET (SDS)
- Update Date: 2025-12-07 19:09:50
What is GSK J1?
Description
GSK-J1 (1373422-53-7) is a potent and selective inhibitor of jumonji H3K27 histone demethylases JMJD3 and UTX (IC50 = 60 nM, human JMJD3). This is the first known inhibitor selective for the H3K27me3-specific JMJ subfamily which binds to the active catalytic site of the enzyme. The COOH group confers cell impermeability and as such GSK-J1 is useful as a standard in in vitro assays. A cell permeable ethyl ester analog is also available, see GSK-J4 (cat.# 10-1394).
The Uses of GSK J1
GSK J1 is a selective and potent inhibitor of JMJDE and UTX demethylases.
What are the applications of Application
GSK J1 is a selective and potent inhibitor of JMJDE and UTX demethylases
Definition
ChEBI: 3-[[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-4-pyrimidinyl]amino]propanoic acid is an organonitrogen heterocyclic compound.
Biochem/physiol Actions
GSK-J1 is also termed as 3-((6-(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoate. It may disturb the differentiation of specific neuronal subtypes in growing rat retina.
Storage
room temperature (desiccate)
References
1) Kruidenier et al. (2012), A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response; Nature, 488 404
Properties of GSK J1
| Boiling point: | 608.9±55.0 °C(Predicted) |
| Density | 1.292±0.06 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | DMSO: soluble15mg/mL, clear |
| form | powder |
| pka | 4.20±0.10(Predicted) |
| color | white to beige |
| Stability: | Stable for 2 years from date of purchase? as supplied. Solutions in DMSO may be stored at -20° for up to 3 months. |
Safety information for GSK J1
| Signal word | Warning |
| Pictogram(s) |
![]() Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for GSK J1
| InChIKey | AVZCPICCWKMZDT-UHFFFAOYSA-N |
New Products
4-Bromo-2-chlorobenzonitrile 1-Chloro-4-Methyl-2-Nitrobenzene 1,3-Diethyl-1,3-Diphenylurea 3-(4-morpholinophenylamino)-5-amino-1H-pyrazole-4-carbonitrile Methyl 2-methylquinoline-6-carboxylate 2-((4-morpholinophenylamino) (methylthio) methylene) malononitrile Chlorodehydromethyl testosterone Cisplatin Prednisolone acetate Benzethonium Chloride Trenbolone Enanthate Testosterone acetate 1,3-Di Iodo Benzene Methyl 2-oxo-2,3-dihydrobenzo[d]oxazole-7-carboxylate 3-Hydroxy-4-nitrobromobenzene 4-(2-Aminoethyl)-7-hydroxy-2H-chromoen-2-one 2-Ethyl-1,4-diaminobenzene 2-Ethylhexyl 4-aminobenzoate Boc-L-Leucinol Calcium Ascorbate Boc-Tyr-OH tert-butyl 2-oxo-1,4,9-triazaspiro[5.5]undecane-9-carboxylate 1-(1-(tert-butoxycarbonyl)piperidin-4-yl)-1H-pyrazole-4-carboxylic acid (1R,5S)-6,6-dimethylbicyclo[3.1.1]heptan-2-oneRelated products of tetrahydrofuran



![4-HYDROXY-2-[(1E)-[4-(1-METHYLETHYL)PHENYL]METHYLENE]HYDRAZIDE](https://img.chemicalbook.in/CAS/GIF/101574-65-6.gif)


![3-[[[2-Methoxy-4-(phenylamino)phenyl]amino]sulfonyl]-2-thiophenecarboxylicacidmethylester](https://img.chemicalbook.in/CAS/GIF/1014691-61-2.gif)

You may like
-
GSK-J1 >95% CAS 1373422-53-7View Details
1373422-53-7 -
GSK-J1 CAS 1373422-53-7View Details
1373422-53-7 -
2124221-11-8 (4-(methylamino)phenyl)methanesulfonic acid 98%View Details
2124221-11-8 -
Boc-Arg-OH HCl H2O 114622-81-0 98%View Details
114622-81-0 -
15761-38-3 Boc-Ala-OH 98%View Details
15761-38-3 -
42074-68-0 98%View Details
42074-68-0 -
20866-46-0 Boc-His(Boc)-OH 98%View Details
20866-46-0 -
2-(4-(tert-butoxycarbonyl)piperazin-2-yl)acetic acid 98%View Details
183591-72-2

